Comorbidities in patients with all-positive symptoms on sinonasal outcomes test quality-of-life instrument

Alexander Caten, Christopher Johnson, David Jang, Jose Gurrola, Stilianos E Kountakis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objectives/Hypothesis The Sinonasal Outcomes Test-20 (SNOT-20) is a validated tool to assess treatment outcomes in patients with chronic rhinosinusitis (CRS). In the clinic, we observed that patients who responded with a positive score on all 20 items of the SNOT-20 questionnaire (pan-positive patients) often did not have evidence of CRS upon workup. Many of these patients had other underlying diseases contributing to their complaints. Methods Analysis of prospectively collected data was performed to identify SNOT-20 pan-positive patients and compare them to 100 consecutive non-pan-positive patients who served as the control group. The following parameters were compared between the two patient groups: presence or absence of chronic diseases such as obstructive sleep apnea, depression, anxiety, fibromyalgia, chronic pain, headaches, temporomandibular joint disease, and arthritis - in addition to sinus computed-tomography Lund-McKay scores and nasal endoscopy Lund-Kennedy scores. We also reviewed the medication list of each patient to look for the possible presence of mental illness. Statistical analysis was performed using the chi-squared and Student t test. Results One hundred twenty-two pan-positive patients were identified in our database collected from 2003 to 2011. Pan-positive patients had higher incidence of depression, fibromyalgia, anxiety, pain, headache, and use of depression medications - and they also had higher SNOT-20 and endoscopy scores when compared to controls (P < 0.05). Pan-positive patients were more likely female (P < 0.05), but age and race differences did not reach statistical significance. Conclusion The SNOT-20 questionnaire assists clinicians to monitor outcomes in patients treated for CRS. However, clinicians should suspect other underlying chronic conditions in SNOT-20 pan-positive patients. Level of Evidence 3B. Laryngoscope, 125:2648-2652, 2015

Original languageEnglish (US)
Pages (from-to)2648-2652
Number of pages5
JournalLaryngoscope
Volume125
Issue number12
DOIs
StatePublished - Dec 1 2015

Fingerprint

Comorbidity
Quality of Life
Fibromyalgia
Depression
Endoscopy
Anxiety
Laryngoscopes
Temporomandibular Joint Disorders
Headache Disorders
Obstructive Sleep Apnea
Nose
Chronic Pain
Arthritis
Headache
Chronic Disease
Tomography
Databases
Students
Pain
Control Groups

Keywords

  • Chronic rhinosinusitis
  • anxiety
  • chronic pain
  • comorbidities
  • depression
  • obstructive sleep apnea
  • sinonasal outcomes test

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Comorbidities in patients with all-positive symptoms on sinonasal outcomes test quality-of-life instrument. / Caten, Alexander; Johnson, Christopher; Jang, David; Gurrola, Jose; Kountakis, Stilianos E.

In: Laryngoscope, Vol. 125, No. 12, 01.12.2015, p. 2648-2652.

Research output: Contribution to journalArticle

Caten, Alexander ; Johnson, Christopher ; Jang, David ; Gurrola, Jose ; Kountakis, Stilianos E. / Comorbidities in patients with all-positive symptoms on sinonasal outcomes test quality-of-life instrument. In: Laryngoscope. 2015 ; Vol. 125, No. 12. pp. 2648-2652.
@article{fc4f9734af44486fb7c18cb15cffe172,
title = "Comorbidities in patients with all-positive symptoms on sinonasal outcomes test quality-of-life instrument",
abstract = "Objectives/Hypothesis The Sinonasal Outcomes Test-20 (SNOT-20) is a validated tool to assess treatment outcomes in patients with chronic rhinosinusitis (CRS). In the clinic, we observed that patients who responded with a positive score on all 20 items of the SNOT-20 questionnaire (pan-positive patients) often did not have evidence of CRS upon workup. Many of these patients had other underlying diseases contributing to their complaints. Methods Analysis of prospectively collected data was performed to identify SNOT-20 pan-positive patients and compare them to 100 consecutive non-pan-positive patients who served as the control group. The following parameters were compared between the two patient groups: presence or absence of chronic diseases such as obstructive sleep apnea, depression, anxiety, fibromyalgia, chronic pain, headaches, temporomandibular joint disease, and arthritis - in addition to sinus computed-tomography Lund-McKay scores and nasal endoscopy Lund-Kennedy scores. We also reviewed the medication list of each patient to look for the possible presence of mental illness. Statistical analysis was performed using the chi-squared and Student t test. Results One hundred twenty-two pan-positive patients were identified in our database collected from 2003 to 2011. Pan-positive patients had higher incidence of depression, fibromyalgia, anxiety, pain, headache, and use of depression medications - and they also had higher SNOT-20 and endoscopy scores when compared to controls (P < 0.05). Pan-positive patients were more likely female (P < 0.05), but age and race differences did not reach statistical significance. Conclusion The SNOT-20 questionnaire assists clinicians to monitor outcomes in patients treated for CRS. However, clinicians should suspect other underlying chronic conditions in SNOT-20 pan-positive patients. Level of Evidence 3B. Laryngoscope, 125:2648-2652, 2015",
keywords = "Chronic rhinosinusitis, anxiety, chronic pain, comorbidities, depression, obstructive sleep apnea, sinonasal outcomes test",
author = "Alexander Caten and Christopher Johnson and David Jang and Jose Gurrola and Kountakis, {Stilianos E}",
year = "2015",
month = "12",
day = "1",
doi = "10.1002/lary.25456",
language = "English (US)",
volume = "125",
pages = "2648--2652",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Comorbidities in patients with all-positive symptoms on sinonasal outcomes test quality-of-life instrument

AU - Caten, Alexander

AU - Johnson, Christopher

AU - Jang, David

AU - Gurrola, Jose

AU - Kountakis, Stilianos E

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Objectives/Hypothesis The Sinonasal Outcomes Test-20 (SNOT-20) is a validated tool to assess treatment outcomes in patients with chronic rhinosinusitis (CRS). In the clinic, we observed that patients who responded with a positive score on all 20 items of the SNOT-20 questionnaire (pan-positive patients) often did not have evidence of CRS upon workup. Many of these patients had other underlying diseases contributing to their complaints. Methods Analysis of prospectively collected data was performed to identify SNOT-20 pan-positive patients and compare them to 100 consecutive non-pan-positive patients who served as the control group. The following parameters were compared between the two patient groups: presence or absence of chronic diseases such as obstructive sleep apnea, depression, anxiety, fibromyalgia, chronic pain, headaches, temporomandibular joint disease, and arthritis - in addition to sinus computed-tomography Lund-McKay scores and nasal endoscopy Lund-Kennedy scores. We also reviewed the medication list of each patient to look for the possible presence of mental illness. Statistical analysis was performed using the chi-squared and Student t test. Results One hundred twenty-two pan-positive patients were identified in our database collected from 2003 to 2011. Pan-positive patients had higher incidence of depression, fibromyalgia, anxiety, pain, headache, and use of depression medications - and they also had higher SNOT-20 and endoscopy scores when compared to controls (P < 0.05). Pan-positive patients were more likely female (P < 0.05), but age and race differences did not reach statistical significance. Conclusion The SNOT-20 questionnaire assists clinicians to monitor outcomes in patients treated for CRS. However, clinicians should suspect other underlying chronic conditions in SNOT-20 pan-positive patients. Level of Evidence 3B. Laryngoscope, 125:2648-2652, 2015

AB - Objectives/Hypothesis The Sinonasal Outcomes Test-20 (SNOT-20) is a validated tool to assess treatment outcomes in patients with chronic rhinosinusitis (CRS). In the clinic, we observed that patients who responded with a positive score on all 20 items of the SNOT-20 questionnaire (pan-positive patients) often did not have evidence of CRS upon workup. Many of these patients had other underlying diseases contributing to their complaints. Methods Analysis of prospectively collected data was performed to identify SNOT-20 pan-positive patients and compare them to 100 consecutive non-pan-positive patients who served as the control group. The following parameters were compared between the two patient groups: presence or absence of chronic diseases such as obstructive sleep apnea, depression, anxiety, fibromyalgia, chronic pain, headaches, temporomandibular joint disease, and arthritis - in addition to sinus computed-tomography Lund-McKay scores and nasal endoscopy Lund-Kennedy scores. We also reviewed the medication list of each patient to look for the possible presence of mental illness. Statistical analysis was performed using the chi-squared and Student t test. Results One hundred twenty-two pan-positive patients were identified in our database collected from 2003 to 2011. Pan-positive patients had higher incidence of depression, fibromyalgia, anxiety, pain, headache, and use of depression medications - and they also had higher SNOT-20 and endoscopy scores when compared to controls (P < 0.05). Pan-positive patients were more likely female (P < 0.05), but age and race differences did not reach statistical significance. Conclusion The SNOT-20 questionnaire assists clinicians to monitor outcomes in patients treated for CRS. However, clinicians should suspect other underlying chronic conditions in SNOT-20 pan-positive patients. Level of Evidence 3B. Laryngoscope, 125:2648-2652, 2015

KW - Chronic rhinosinusitis

KW - anxiety

KW - chronic pain

KW - comorbidities

KW - depression

KW - obstructive sleep apnea

KW - sinonasal outcomes test

UR - http://www.scopus.com/inward/record.url?scp=84936818108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936818108&partnerID=8YFLogxK

U2 - 10.1002/lary.25456

DO - 10.1002/lary.25456

M3 - Article

VL - 125

SP - 2648

EP - 2652

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 12

ER -